Lactobacillus-Polydopamine System for Targeted Drug Delivery in Overactive Bladder: Evidence from Bladder Cell Spheroids, Rat Models, and Urinary Microbiome Profiling
Profiling (computer programming)
Spheroid
DOI:
10.2147/ijn.s465745
Publication Date:
2024-08-15T04:50:15Z
AUTHORS (11)
ABSTRACT
Introduction:Overactive bladder (OAB) is a highly prevalent condition with limited treatment options due to poor efficacy, side effects, and patient compliance.Novel drug delivery systems that can target the wall may improve OAB therapy.Methods: We explored polydopamine (PDA)-coated lactobacillus platform as potential carrier for localized treatment.Urinary microbiome profiling was performed identify presence of in healthy groups.Lactobacillus-PDA nanoparticles were synthesized characterized by electron microscopy spectrophotometry.A rat perfusion model human smooth muscle cell spheroids used assess distribution penetration nanoparticles.The efficacy Lactobacillus-PDA system (LPS) delivering antimuscarinic solifenacin evaluated an model.Results: Urinary revealed dominant genus both groups.The exhibited uniform size optical properties.In model, distributed throughout without toxicity.The also penetrated spheroids.In LPS facilitated improved efficacy.Discussion: The results highlight promising targeted therapy via into tissues.This bacteriotherapy approach overcome limitations current systemic medications.Lactobacillus, probiotic bacterium present urinary tract microbiome, hypothesized adhere penetrate when coated PDA nanoparticles, making it suitable candidate delivery.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (46)
CITATIONS (1)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....